In last trading session, ReShape Lifesciences Inc (NASDAQ:RSLS) saw 7.59 million shares changing hands with its beta currently measuring 1.49. Company’s recent per share price
ReShape Lifesciences Inc (NASDAQ:RSLS) has a beta value of 1.60 and has seen 244.39 million shares traded in the last trading session. The company, currently
ReShape Lifesciences Inc (NASDAQ:RSLS) has a beta value of 1.60 and has seen 140.88 million shares traded in the recent trading session. The company, currently
During the last session, ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares were 0.84 million, with the beta value of the company hitting 1.53. At the end
In the last trading session, 1.34 million shares of the ReShape Lifesciences Inc (NASDAQ:RSLS) were traded, and its beta was 1.43. Most recently the company’s
During the last session, ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares were 0.42 million, with the beta value of the company hitting 1.33. At the end
ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting 1.60. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
